바실러스 코아귤런스 시장 예측(-2030년) : 제품 유형별, 형태별, 유통 채널별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Bacillus Coagulans Market is accounted for $103 million in 2023 and is expected to reach $202 million by 2030 growing at a CAGR of 10.1% during the forecast period. Bacillus coagulans is a beneficial bacterium commonly used as a probiotic due to its ability to promote digestive health and support immune function. It is a spore-forming, lactic acid-producing bacterium that can survive harsh conditions such as heat, acidity, and bile salts, making it highly resilient and effective as a dietary supplement. Bacillus coagulans aids in maintaining a healthy balance of gut flora by inhibiting the growth of harmful bacteria and promoting the growth of beneficial bacteria.

Market Dynamics:

Driver:

Expansion of the probiotics

Probiotics have gained considerable attention due to their potential health benefits, particularly in supporting digestive health and immune function. As a probiotic bacterium, Bacillus coagulans has benefited from this growing market trend. Furthermore, healthcare professionals and researchers have been actively promoting the benefits of probiotics, including Bacillus coagulans, through scientific studies and clinical trials. Positive findings from these studies have contributed to the credibility and acceptance of probiotics as a viable health solution, further propelling market expansion.

Restraint:

Product stability

Bacillus coagulans is a live bacterium that is sensitive to various environmental factors, including temperature, moisture, and oxygen exposure. However, Bacillus coagulans may have specific requirements for optimal growth and survival, including pH levels, nutrient availability, and compatibility with other ingredients. Maintaining the stability and viability of Bacillus coagulans throughout the product's shelf life can be challenging, and product instability can affect its effectiveness and consumer trust, which hampers the market demand.

Opportunity:

Increasing consumer awareness

As consumers become more conscious of their health and well-being, there is a growing demand for natural and effective solutions to support digestive health. Bacillus coagulans, with its properties, has gained attention as a potential remedy, leading to increased consumer awareness and demand. Furthermore, health and wellness publications, online resources, social media, and word-of-mouth recommendations have all played a role in educating consumers about the benefits of Bacillus coagulans.

Threat:

Competition from alternative products

Alternative probiotic strains, such as Lactobacillus and Bifidobacterium species, offer similar health benefits and are well-established in the market, creating a competitive landscape. Additionally, non-probiotic alternatives, such as prebiotics, synbiotics, and conventional pharmaceuticals, compete for market share by targeting similar health conditions or wellness goals. The presence of established competitors and alternative products underscores the importance of differentiation and value proposition for Bacillus coagulans products, which impact the market demand.

Covid-19 Impact

The global Bacillus Coagulans market has experienced significant impacts due to the COVID-19 pandemic. The pandemic has led to a revaluation of health priorities, resulting in an increased demand for functional foods and probiotics, including Bacillus Coagulans. Moreover, the pandemic has caused disruptions in the supply chain, impacting the commercial manufacturing of functional food products in various regions.

The powder segment is expected to be the largest during the forecast period

The powder segment is estimated to hold the largest share, due to their versatility, convenience, and ease of incorporation into various applications. Bacillus coagulans powder is a concentrated form of the probiotic bacterium, often used in dietary supplements, functional foods, and animal feed additives. Moreover, powdered Bacillus coagulans supplements offer consumers a convenient way to incorporate probiotics into their daily routines. The powder can be easily mixed into beverages, yogurt, or sprinkled over food, providing a simple and customizable way to boost gut health and immunity.

The non-dairy segment is expected to have the highest CAGR during the forecast period

The non-dairy segment is anticipated to have lucrative growth during the forecast period, due to the increasing demand for dairy-free and vegan-friendly probiotic products. Bacillus coagulans, being a resilient spore-forming bacterium, is well-suited for incorporation into non-dairy foods and beverages, offering consumers alternative options for obtaining the health benefits associated with probiotics. Moreover, the growing trend towards clean label and natural ingredients has further fuelled the demand for non-dairy probiotic options, as Bacillus coagulans is often perceived as a natural and clean-label-friendly ingredient.

Region with largest share:

North America commanded the largest market share during the extrapolated period. With increasing awareness among consumers about the importance of digestive health and wellness, there has been a growing demand for products containing Bacillus coagulans. This demand is driven by factors such as hectic lifestyles, poor dietary habits, and rising incidences of digestive disorders. Moreover, the regulatory environment in North America, particularly in the United States and Canada, supports the use of bacillus coagulans in food and dietary supplements, further driving its market growth.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, due to large and diverse population, increasing disposable income, and rising health consciousness. Bacillus coagulans, with its ability to withstand high temperatures and acidic environments, is well-suited for fermentation processes, making it a popular choice for enhancing the nutritional value and probiotic content of traditional Asian foods like kimchi, miso, tempeh, and pickles. Furthermore, the prevalence of gastrointestinal disorders and digestive health concerns in the region has heightened awareness of the importance of gut health and probiotics.

Key players in the market

Some of the key players in the Bacillus Coagulans Market include Mitsubishi Chemical Foods Corporation, Aumgene Bioscience, Nebraska Cultures, Syngen Biotech, Sabinsa Corporation, UAS Laboratories, Ganeden, Microbax, Mystical Biotech Pvt. Ltd, Sanzyme, Synbiotics Limited, Lallemand Inc., Bioriginal Food & Science Corp., Unique Biotech Limited and Biovation Labs Inc.

Key Developments:

In February 2024, Bioriginal Food & Science Corp. a wholly-owned subsidiary of Cooke Inc., has announced the acquisition of POS Biosciences Corp. (Saskatoon, Saskatchewan, Canada) from Canopy Growth Corp.

In October 2023, Bioriginal Food & Science Corp. has expanded into Germany with the acquisition of Pflanzenolmuhle Kroppenstedt GmbH operating as Kroppenstedter Olmuhle, a century-old, family-owned mill that specializes in the pressing of plant-based oil products from conventional and organic sources.

In August 2023, Synbiotics Limited acquired CannaCare Health GmbH with its strong CBD brand Canobo as well as the emerging CBD network marketing subsidiary WellnetIQ.

In April 2021, Mitsubishi Chemical Corporation has entered into a partnership agreement with Dymon Co., Ltd. the robot and space development venture, the first private company ever to explore the moon. Based on this agreement, MCC will provide carbon fiber reinforced plastic (CFRP) components and thermoplastic materials as well as technical support.

Product Types Covered:

• Animal-Based
• Plant-Based

Forms Covered:

• Spore
• Liquid
• Powder

Distribution Channels Covered:

• Offline Retail
• Online Retail

Applications Covered:

• Cereal
• Infant Nutrition
• Non-Dairy
• Probiotic Supplements
• Other Applications

End Users Covered:

• Food & Beverages
• Cosmetics
• Nutraceuticals
• Pharmaceutical
• Animal Husbandry
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Bacillus Coagulans Market, By Product Type

• 5.1 Introduction
• 5.2 Animal-Based
• 5.3 Plant-Based

6 Global Bacillus Coagulans Market, By Form

• 6.1 Introduction
• 6.2 Spore
• 6.3 Liquid
• 6.4 Powder

7 Global Bacillus Coagulans Market, By Distribution Channel

• 7.1 Introduction
• 7.2 Offline Retail
• 7.3 Online Retail

8 Global Bacillus Coagulans Market, By Application

• 8.1 Introduction
• 8.2 Cereal
• 8.3 Infant Nutrition
• 8.4 Non-Dairy
• 8.5 Probiotic Supplements
• 8.6 Other Applications

9 Global Bacillus Coagulans Market, By End User

• 9.1 Introduction
• 9.2 Food & Beverages
• 9.3 Cosmetics
• 9.4 Nutraceuticals
• 9.5 Pharmaceutical
• 9.6 Animal Husbandry
• 9.7 Other End Users

10 Global Bacillus Coagulans Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Mitsubishi Chemical Foods Corporation
• 12.2 Aumgene Bioscience
• 12.3 Nebraska Cultures
• 12.4 Syngen Biotech
• 12.5 Sabinsa Corporation
• 12.6 UAS Laboratories
• 12.7 Ganeden
• 12.8 Microbax
• 12.9 Mystical Biotech Pvt. Ltd
• 12.10 Sanzyme
• 12.11 Synbiotics Limited
• 12.12 Lallemand Inc.
• 12.13 Bioriginal Food & Science Corp.
• 12.14 Unique Biotech Limited
• 12.15 Biovation Labs Inc.